Expression mapping at 12p12-13 in advanced prostate carcinoma

Adam S. Kibel, John Huagen, Chan Guo, William B. Isaacs, Yan Yan, Kenneth J. Pienta, Paul J. Goodfellow

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


We have previously mapped a putative prostate cancer tumor-suppressor gene to a 1-2 Mb region of 12p12-13. Initial work to identify the tumor suppressor at this locus focused on candidates previously implicated in malignancy; however, mutational and methylation analyses failed to identify significant genomic events. An alternative approach is to use expression analysis to prioritize the genes within the region of interest. This experimental design is based on the hypothesis that tumor-suppressor genes demonstrate decreased expression in tumors compared to normals. Herein, we narrow the region of interest using deletion mapping data and employ expression analysis to prioritize the genes in the minimal deleted region. Highly informative polymorphic markers spanning our region were used to assess for loss of heterozygosity in 99 tumor and normal DNA pairs. The minimal region of deletion was determined to be approximately 500 kb bounded by D 12S391 and A002Q26. Publically available databases place 7 genes within this minimal deletion region. An additional 3 genes lie just outside this minimal deletion region and could possibly be inactivated by deletion of promoter, 3′-untranslated region sequences or alternative splice variants. Relative levels of expression of these 10 candidate genes were determined in 6 normal prostates, 5 local prostate tumors, 9 prostate lymph node metastases, 6 prostate cancer cell lines and 12 prostate cancer xenografts using quantitative RT-PCR. DUSP16, FLJ10298 and BCLG were significantly downregulated in both clinical tumors and cultured prostate cancer tissue, indicating that one or all may be critical to initiation or progression of prostate carcinoma.

Original languageEnglish (US)
Pages (from-to)668-672
Number of pages5
JournalInternational Journal of Cancer
Issue number5
StatePublished - May 1 2004


  • 12p12-13
  • DNA analysis
  • Genetics
  • Loss of heterozygosity
  • Prostatic neoplasm
  • RNA analysis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Expression mapping at 12p12-13 in advanced prostate carcinoma'. Together they form a unique fingerprint.

Cite this